| (MXN) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 4.40B | — |
| Operating expense | — | — |
| Net income | 374.49M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, LABB.MX returned -36.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -22.3% |
| 1 year | -36.0% |
| 5 years | -9.6% |
| 10 years | -16.8% |
| All-time high | $38.41 (Nov 2013) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in LABB.MX would be worth today ›Yes. Genomma Lab Internacional, S.A.B. de C.V. paid 4 dividends over the past 12 months. The most recent was $0.20 per share on Jun 26, 2026. The dividend yield is 5.90%.
Genomma Lab Internacional, S.A.B. de C.V. is part of the Healthcare sector.
Genomma Lab Internacional, S.A.B. de C.V. has a market cap of 13.28B MXN, based on the latest quote.
Genomma Lab Internacional, S.A.B. de C.V. is scheduled to report earnings on Oct 21, 2026.
